The rate of visual field change in the ocular hypertension treatment study

Investigative Ophthalmology and Visual Science

Volumn 53, Issue 1, 2012, Pages 224-227

  Demirel, Shaban ^a   de Moraes, Carlos Gustavo V ^b,c   Gardiner, Stuart K ^a   Liebmann, Jeffrey M ^b,c   Cioffi, George A ^a   Ritch, Robert ^b,d   Gordon, Mae O ^e   Kass, Michael A ^e  

^a DEVERS EYE INSTITUTE   (United States)

^b NEW YORK EYE AND EAR INFIRMARY   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NEW YORK MEDICAL COLLEGE   (United States)

^e WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; FOLLOW UP; HUMAN; HUMAN EXPERIMENT; INTRAOCULAR HYPERTENSION; LINEAR REGRESSION ANALYSIS; OPEN ANGLE GLAUCOMA; OPTIC DISK; PRIORITY JOURNAL; VISUAL FIELD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; INTRAOCULAR PRESSURE; LABORATORY DIAGNOSIS; OPTIC NERVE DISEASE; PATHOLOGY; PATHOPHYSIOLOGY; PERIMETRY; PHYSIOLOGY; PREDICTIVE VALUE; RANDOMIZED CONTROLLED TRIAL; VISUAL DISORDER;

DISEASE PROGRESSION; FALSE POSITIVE REACTIONS; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; OCULAR HYPERTENSION; OPTIC DISK; OPTIC NERVE DISEASES; PREDICTIVE VALUE OF TESTS; VISION DISORDERS; VISUAL FIELD TESTS; VISUAL FIELDS;

EID: 84859260090     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.10-7117     Document Type: Article

References (34)

1. Kass MA, Heuer DK, Higginbotham EJ, et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120:701-713, discussion 829-730.
2. Gordon MO, Beiser JA, Brandt JD, et al. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120:714-720, discussion 829-730.
3. Higginbotham EJ, Gordon MO, Beiser JA, et al. The Ocular Hypertension Treatment Study: topical medication delays or prevents primary open-angle glaucoma in African American individuals. Arch Ophthalmol. 2004;122:813-820.
4. Zangwill LM, Weinreb RN, Beiser JA, et al. Baseline topographic optic disc measurements are associated with the development of primary open-angle glaucoma: the Confocal Scanning Laser Ophthalmoscopy Ancillary Study to the Ocular Hypertension Treatment Study. Arch Ophthalmol. 2005;123:1188-1197.
5. Budenz DL, Anderson DR, Feuer WJ, et al. Detection and prognostic significance of optic disc hemorrhages during the Ocular Hypertension Treatment Study. Ophthalmology. 2006;113:2137-2143.
6. Levine RA, Demirel S, Fan J, Keltner JL, Johnson CA, Kass MA. Asymmetries and visual field summaries as predictors of glaucoma in the ocular hypertension treatment study. Invest Ophthalmol Vis Sci. 2006;47:3896-3903.
7. Klewin KM, Radius RL. Background illumination and automated perimetry. Arch Ophthalmol. 1986;104:395-397.
8. Haas A, Flammer J, Schneider U. Influence of age on the visual fields of normal subjects. Am J Ophthalmol. 1986;101:199-203.
9. Heuer DK, Anderson DR, Feuer WJ, Gressel MG. The influence of decreased retinal illumination on automated perimetric threshold measurements. Am J Ophthalmol. 1989;108:643-650.
10. Lindenmuth KA, Skuta GL, Rabbani R, Musch DC. Effects of papillary constriction on automated perimetry in normal eyes. Ophthalmology. 1989;96:1298-1301.
11. Lindenmuth KA, Skuta GL, Rabbani R, Musch DC, Bergstrom TJ. Effects of pupillary dilation on automated perimetry in normal patients. Ophthalmology. 1990;97:367-370.
12. Henson DB, Morris EJ. Effect of uncorrected refractive errors upon central visual field testing. Ophthalmic Physiol Opt. 1993;13:339-343.
13. Gordon MO, Kass MA. The Ocular Hypertension Treatment Study: design and baseline description of the participants. Arch Ophthalmol. 1999;117:573-583.
14. Miglior S, Zeyen T, Pfeiffer N, Cunha-Vaz J, Torri V, Adamsons I. The European Glaucoma Prevention Study design and baseline description of the participants. Ophthalmology. 2002;109:1612-1621.
15. Musch DC, Lichter PR, Guire KE, Standardi CL. The Collaborative Initial Glaucoma Treatment Study: study design, methods, and baseline characteristics of enrolled patients. Ophthalmology. 1999;106:653-662.
16. The Advanced Glaucoma Intervention Study Group. The Advanced Glaucoma Intervention Study (AGIS), 1: study design and methods and baseline characteristics of study patients. Controlled Clin Trials 1994;15:299-325.
17. Keltner JL, Johnson CA, Quigg JM, Cello KE, Kass MA, Gordon MO. Confirmation of visual field abnormalities in the Ocular Hypertension Treatment Study. Ocular Hypertension Treatment Study Group. Arch Ophthalmol. 2000;118:1187-1194.
18. Bengtsson B, Heijl A. A visual field index for calculation of glaucoma rate of progression. Am J Ophthalmol. 2008;145:343-353.
19. Fitzke FW, Hitchings RA, Poinoosawmy D, McNaught AI, Crabb DP. Analysis of visual field progression in glaucoma. Br J Ophthalmol. 1996;80:40-48.
20. Gardiner SK, Crabb DP. Examination of different pointwise linear regression methods for determining visual field progression. Invest Ophthalmol Vis Sci. 2002;43:1400-1407.
21. Manassakorn A, Nouri-Mahdavi K, Koucheki B, Law SK, Caprioli J. Pointwise linear regression analysis for detection of visual field progression with absolute versus corrected threshold sensitivities. Invest Ophthalmol Vis Sci. 2006;47:2896-2903.
22. R Development Core Team. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2010.
23. Yan J, Fine J. Estimating equations for association structures. Stat Med. 2004;23:859-874.
24. Yan J. geepack: Yet Another Package for Generalized Estimating Equations. R-News;2002:12-14.
25. Bengtsson B, Olsson J, Heijl A, Rootzen H. A new generation of algorithms for computerized threshold perimetry, SITA. Acta Ophthalmol Scand. 1997;75:368-375.
26. Bengtsson B, Heijl A, Olsson J. Evaluation of a new threshold visual field strategy, SITA, in normal subjects: Swedish Interactive Thresholding Algorithm. Acta Ophthalmol Scand. 1998;76:165-169.
27. Bengtsson B, Heijl A. Evaluation of a new perimetric threshold strategy, SITA, in patients with manifest and suspect glaucoma. Acta Ophthalmol Scand. 1998;76:268-272.
28. Bengtsson B, Heijl A. Comparing significance and magnitude of glaucomatous visual field defects using the SITA and Full Threshold strategies. Acta Ophthalmol Scand. 1999;77:143-146.
29. Shirato S, Inoue R, Fukushima K, Suzuki Y. Clinical evaluation of SITA: a new family of perimetric testing strategies. Graefes Arch Clin Exp Ophthalmol. 1999;237:29-34.
30. Musch DC, Gillespie BW, Motyka BM, Niziol LM, Mills RP, Lichter PR. Converting to SITA-standard from full-threshold visual field testing in the follow-up phase of a clinical trial. Invest Ophthalmol Vis Sci. 2005;46:2755-2759.
31. Chauhan BC, Garway-Heath DF, Goni FJ, et al. Practical recommendations for measuring rates of visual field change in glaucoma. Br J Ophthalmol. 2008;92:569-573.
32. Kass MA, Gordon MO, Gao F, et al. Delaying treatment of ocular hypertension: the Ocular Hypertension Treatment Study. Arch Ophthalmol. 2010;128:276-287.
33. Wild JM, Hutchings N, Hussey MK, Flanagan JG, Trope GE. Pointwise univariate linear regression of perimetric sensitivity against follow-up time in glaucoma. Ophthalmology. 1997;104:808-815.
34. Artes PH, O'Leary N, Hutchison DM, et al. Properties of the Statpac Visual Field Index. Invest Ophthalmol Vis Sci. 2011;52:4030-4038.